The use of preventive tuberculosis treatment after Mycobacterium tuberculosis infection, historically with isoniazid and more recently with shorter-duration rifamycin regimens, is a core component of tuberculosis control in the United States and is increasingly being used in some tuberculosis-endemic areas.1 However, multidrug-resistant (MDR) tuberculosis, which is…
The New England Journal of Medicine: Search Results in Pediatrics
